T 1352/19 of 18.02.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T135219.20220218
- Date of decision
- 18 February 2022
- Case number
- T 1352/19
- Petition for review of
- -
- Application number
- 11769800.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID
- Applicant name
- Altergon S.A.
- Opponent name
- Fidia Farmaceutici S.p.A.
- Board
- 3.3.03
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Extension of subject-matter (no)
New objections (novelty and inventive step) after summons - no exceptional circumstances
Novelty - (yes)
Inventive step (yes)
Inventive step - no bonus effect
New documents submitted in relation to sufficiency of disclosure after rejoinder and before summons - admitted (yes)
Sufficiency of disclosure (yes) - Catchword
- -
- Cited cases
- G 0003/14
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the claims of the main request filed with the statement of grounds of appeal and after necessary consequential amendments to the description.